Código QR (código de barras bidimensional)

Non-infectious occlusive retinal vasculitis following switching from aflibercept 2 mg to aflibercept 8 mg in neovascular age-related macular degeneration: a case report

Abstract Background Anti–vascular endothelial growth factor (anti-VEGF) therapy represents the standard of care for neovascular age-related macular degeneration (nAMD). Aflibercept 8 mg was recently introduced with extended dosing intervals and favorable safety outcomes in phase III trials. Although...

Fuld beskrivelse

Na minha lista:
Principais autores: Ermal Simaku, Ahmed Nour Eddien, Megi Popa, Ahmed El Shafei
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2026-05-01
Serier:BMC Ophthalmology
Fag:
Neovascular age-related macular degeneration
Aflibercept 8 mg
Retinal vasculitis
Anti-VEGF
Drug-induced inflammation
Pharmacovigilance
Online adgang:https://doi.org/10.1186/s12886-026-04953-z
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker